Objectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014

Size: px
Start display at page:

Download "Objectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014"

Transcription

1 ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management Matthew Fricker, RPh, MS, FASHP Program Director, ISMP Rebecca Lamis, PharmD, FISMP Medication Safety Analyst, ISMP May 22, 2014 Objectives Discuss strategies to enhance the content of orientation and educational programs and staff competency evaluations Recognize the importance of a culture of safety within your organization and provide methods for identifying and analyzing risk Review the ICAHN aggregate self assessment results for these areas 2 Key Elements Key Element Mean % VI Drug Device Acquisition, Use, Monitoring 51% VIII Staff Competency and Education 55% I Patient Information 56% II Drug Information 56% IX Patient Education 63% X Quality Processes and Risk Management 63% IV Drug Labeling, Packaging, Nomenclature 65% III Communication of Drug Orders and Other Drug Info. 70% V Drug Standardization, Storage, Distribution 73% VII Environmental Factors, Workflow, Staffing Patterns 81% Total 63% 3 1

2 Rank Order of Error Reduction Strategies Strategy Fail safes and constraints Forcing functions Automation and computerization Standardization Redundancies Reminders and checklists Rules and policies Education and information Suggestions to be more vigilant Power (Leverage) High ( Blunt end ) Medium Low ( Sharp end ) 4 Staff Competency and Education Although staff education is a weak error reduction strategy alone, it plays an important role when combined with system based error reduction strategies Activities with the highest leverage include: Ongoing assessment of healthcare providers baseline competencies Education about new medications, non formulary medications, high alert medications, and medication error prevention 5 Problems with Staff Competency and Education Inadequate orientation process and baseline competency validation Competencies inconsistent throughout organization Lack of standardized, interdisciplinary education Inconsistent credentialing, training, and certification Lack of sharing information about errors (internal and external), their causes, and prevention 6 2

3 Core Characteristic #14: Practitioners receive orientation to medication use and undergo competency evaluations (57%) 7 What Should be Included in Orientation? Understanding of the entire medication use process Nurses spend time in the pharmacy Pharmacists spend time on patient care units Specific processes and procedures related to the provision of care, treatment, and services Technology training and assessment of use Medication errors and risk reduction strategies Staff is oriented to the key safety content before providing care, treatment, and services 8 Nurses Spend Time in the Pharmacy 173 During orientation, nurses spend time in the pharmacy (and with clinical pharmacists) to become familiar with the order entry and/or verification process, drug preparation and dispensing, availability of drug information resources, ways to access these resources, and various medication safety initiatives. 43% 50% 7% 9 3

4 Pharmacists Spend Time in Care Units 174 During orientation, pharmacists spend time in patient care units to become familiar with drug prescribing practices, unit stock storage conditions, medication administration procedures, and patient education processes. 29% 29% 43% 10 Pharmacists Participate in Medical Staff Orientation 175 Pharmacists actively participate in the orientation process for new medical staff (including medical students, medical residents, and attending physicians). 57% 29% 14% 11 Teamwork Training 183 The organization provides formal teamwork training (e.g., TeamSTEPPS) to all staff that incorporates elements of information sharing, conflict resolution, communication and teamwork skills, and clarification of team roles and responsibilities. 71% 21% 7% 12 4

5 Medication Error Information Provided During Orientation 172 During orientation and on a routine basis, staff participating in the medication use process, receive information about the hospital s actual error experiences as well as published errors that have occurred in other facilities; and they are educated about system based strategies to reduce the risk of such errors. 36% 50% 14% 13 Specialty Pharmacists/Nurses Undergo Training 176 All prescribers, pharmacists, and nurses who work in specialty areas (e.g., critical care, pediatrics, oncology) undergo extensive training and/or obtain certification if available in that specialty before working independently. 7% 57% 36% 14 Qualified and Trained Specialty Pharmacists 167 The organization has an adequate complement of well qualified and trained pharmacists to work in specialty areas or provide services to specialty populations (e.g., critical care, pediatric, neonatal, and oncology patients) that represent a substantial portion of the organization's patient population. 0% 21% 79% 15 5

6 Qualified and Trained Specialty Nurses 168 The organization has an adequate complement of well qualified and trained nurses to provide care to specialty populations (e.g., critical care, pediatric, neonatal, and oncology patients) that represent a substantial portion of the organization's patient population. 7% 7% 86% 16 Baseline Competency Evaluation 171 All new staff participating in the medication use process, including agency staff, undergo baseline competency evaluation before working independently. 29% 14% 57% 17 Topics to Include in Orientation and Baseline Competency Safe practices around medication use At risk behaviors Technology Error reporting/risk identification 18 6

7 Topics to Include in Orientation and Baseline Competency System based causes of medication errors High leverage strategies for risk reduction Examples of medication errors Internally reported Externally reported 19 Examples of Competencies for Nurses Consistently measure and document height and weight using the metric system (only) Demonstrate ability to communicate effectively, e.g., SBAR (situation, background, assessment, recommendation) i.e., verbalize the importance of sharing essential patient information between practitioner groups 20 Examples of Competencies for Nurses Order clarification process Utilize drug information resources as necessary Consistently use two unique patient identifiers Understand and utilize the correct procedure for an independent double check 21 7

8 Examples of Competencies for Pharmacists Verify all orders using the patient s complete profile before entering new orders or adjusting current medications Utilize laboratory parameters to evaluate the proper dosing of drug therapy Recognize appropriate (and inappropriate) therapy for patients based on their disease states and past history 22 Examples of Competencies for Pharmacists Clarify any incomplete or inappropriate orders with the prescriber Complete all steps in the checking process for IV preparations Additional checks required for high alert products? Technology Compounders Robotics Carousels 23 Examples of Competencies for Prescribers Need for complete orders Avoidance of dangerous abbreviations and dose expressions for all orders Use of mg/kg and total dose for pediatric/neonatal orders Formulary control Benefits of standardization Technology CPOE 24 8

9 Examples of At Risk Behaviors Accepting incomplete orders (verbal and written) Only repeating back telephone orders (not writing down/reading back) Administering medications without orders Not taking the MAR to the ADC or bedside Borrowing another patient's medications Not labeling syringes, bowels, etc. Mathematical calculations of doses not independently checked Use of dangerous abbreviations 25 Items on Error Reporting Organization s definition of a medication error What is reportable in your organization? Sentinel event Medication errors (reaching the patient) Close calls Error reporting procedures Reporting mechanism 26 Items on Error Reporting Methods for responding to errors Root cause analysis Proactive risk reduction activity (FMEA) Error reduction strategies How information is used 27 9

10 Core Characteristic #15: Provide ongoing education about medication error prevention and the safe use of drugs to staff (53%) 28 Identifying and Reducing Risk 194 Senior leaders, management, and frontline staff receive formal training in identifying risk within the system and incorporating high leverage errorreduction strategies to help eliminate the risk. 36% 36% 29% 29 Human Factors 193 Human factors and the principles of error reduction (e.g., standardization, use of constraints, redundancy for critical functions) are introduced during practitioner orientation, and used as the foundation for an annual mandatory educational program for all practitioners involved in the medication use process. 57% 29% 14% 30 10

11 Widespread Education 190 When errors occur, educational efforts are widespread among all practitioners who could make a similar error, rather than remedial and directed at only those practitioners who were involved in an error. 21% 36% 43% 31 Ongoing Medication Error Information 186 Practitioners receive ongoing information about medication errors occurring within the organization, error prone conditions, errors occurring in other healthcare facilities, and strategies to prevent such errors. 14% 43% 43% 32 Methods of Education Periodic medication safety tips via Safety updates on the intranet or a medication safety website Storyboards or other poster formats to describe medication safety initiatives and results (often used at an annual skills day/employee updates) 33 11

12 Methods of Education Communication logs used to share safety tips in patient care areas Videos and computer based training courses Weekly multidisciplinary safety rounds with frontline staff and management involvement Simulation exercises 34 Simulations/Role Playing of Error Prone Conditions 192 Simulations of error prone conditions (e.g., problematic medication packages and labels, mock transcription/order entry of problematic orders) and/or role playing (e.g., to teach effective communication skills, inquiry skills, conflict resolution) are used as methodologies to orient and educate practitioners and other staff about medication/patient safety. 71% 29% 0% 35 Examples of Topics for Staff Education Safety strategies with high alert medications, for example opioids Opioid equianalgesic dosing (e.g., HYDROmorphone) Transdermal patch safety PCA safety New drugs added to the formulary Practice guidelines for using newly implemented technology safely 36 12

13 Key Elements Key Element Mean % VI Drug Device Acquisition, Use, Monitoring 51% VIII Staff Competency and Education 55% I Patient Information 56% II Drug Information 56% IX Patient Education 63% X Quality Processes and Risk Management 63% IV Drug Labeling, Packaging, Nomenclature 65% III Communication of Drug Orders and Other Drug Info. 70% V Drug Standardization, Storage, Distribution 73% VII Environmental Factors, Workflow, Staffing Patterns 81% Total 63% 37 Culture eats strategy for lunch everyday! That s the way we do things around here. Organizational safety culture is the most critical, underlying predictor of accomplishments related to safety. 38 Culture of Safety Achievement of sustainable medication safety goals requires lasting culture change Two strong predictors that healthcare workers will adopt patient safety behaviors Observed behaviors of professional peers Genuine belief in the safety outcomes of the behaviors Work in progress in most organizations Marathon not a sprint, but sense of urgency needed 39 13

14 Leaders Demonstrate Commitment to Patient Safety There is a visible commitment to patient safety within the organization that is evident in the behaviors of hospital leaders and managers. The Board of Trustees/Directors actively demonstrates its commitment to patient safety (and safe medication practices) by approving a safety plan, rewarding practitioner error reporting, approving system design enhancements, including technology, that are likely to reduce errors, and incorporating patient safety and quality as a routine and significant component of each board meeting. 0% 43% 57% 7% 43% 50% 40 Safety Structure Components Culture Medication safety committee Strategic plan Medication Safety Practitioner 41 Factors Affecting Error Reporting Culture Anonymously survey practitioners Provides valuable insight Identify strengths and weaknesses in current culture Level of anxiety and fear with making errors and reporting error Ease of reporting errors and receiving feedback Online incident reporting Hotline available Timely feedback; follow up is key to any system 42 14

15 Culture Surveys 220 Practitioners are anonymously surveyed at least annually to assess the organization s safety culture. 64% 29% 7% 215 Practitioners and other staff report and openly discuss errors without embarrassment or fear of reprisal from the hospital/organization. Scoring guideline: If possible, choose A through E based on staff surveys as noted in item 220 7% 36% 57% 43 Internally Reported Errors are Analyzed 234 A convened interdisciplinary team, which includes at a minimum, risk management/quality improvement professionals, pharmacists, nurses, physicians, clinical information technology staff, and hospital leadership, meets at least monthly to review internal medication error/hazard reports, sentinel events, and other medication safety data, to identify the system based causes of error, and to facilitate the implementation of system design enhancements that make it difficult or impossible for practitioners to err. 14% 36% 50% 44 Feedback about Reported Errors 244 Prescribers, pharmacists, and nurses are provided with regular feedback about reported errors, hazardous situations, and error reduction strategies that are being implemented. 7% 50% 43% 45 15

16 Tip of the Iceberg Incident reports (Medication errors reported) Retrospective analysis Observation (Medication errors occurring) 46 Not Just Using Error Reports to Measure Medication Safety 247 An effective means of measuring medication safety (e.g., random chart review using triggers, tracking risk priority numbers from FMEAs, observational methods of error detection, measuring compliance with new medication protocols, drug use evaluations), which does not rely on practitioner reported data, has been designed and implemented to uncover systembased problems and to demonstrate sustained improvement after implementation of risk reduction strategies. 14% 64% 21% 47 Methods of Data Collection Proactive risk assessment Self assessments Failure Mode and Effects Analysis (FMEA) External sources of data ISMP s Quarterly Action Agenda The Joint Commission Sentinel Event Alert FDA alerts Concurrent risk assessment Pharmacy interventions Triggers and markers 48 16

17 Medication Use Process is Analyzed 233 The entire medication use process is analyzed at least annually (e.g., using a proactive risk assessment tool such as this self assessment) to identify potential risk factors for medication errors. 50% 43% 7% 49 Team Analyzes Outside Errors 240 A convened interdisciplinary team routinely analyzes and uses published error experiences from other organizations to assess the organization s vulnerability to similar errors and proactively target improvements in the medication use process. 43% 29% 29% 50 Dispensing and Prescribing Errors are Analyzed 242 Drug selection, preparation, and labeling errors identified during routine checking processes are reported and collected for the purpose of identifying system design issues and developing error prevention strategies. 14% 29% 57% 243 Prescribing errors that are detected by pharmacists and nurses are recorded, analyzed, and used in conjunction with medical staff quality improvement activities for system redesign 0% 50% 50% 51 17

18 Use of Triggers 241 In addition to practitioner reporting systems, computer markers or triggers for selected drug orders (such as antidotes) and laboratory tests (such as aptt greater than 100) are used to enhance detection of potential adverse drug events (both medication errors and adverse drug reactions). 14% 64% 21% 52 Methods of Data Collection Retrospective risk assessment Observational methodology WalkRounds Data from technology Smart pumps, ADCs, pharmacy system Chart reviews Rapid Response Teams Fall data Internal, voluntary reporting Close calls and good catches 53 Leadership WalkRounds 228 Senior leaders (administrative staff, board members when possible) participate in frequent, structured visits (e.g., WALKROUNDS to patient care units, the pharmacy, and laboratories to talk to frontline staff about safety and quality issues, learn first hand about day to day challenges that staff face when providing care and services, and show their support for staff reported errors. 29% 43% 29% 54 18

19 Off the Record Discussions 232 Trusted nurse, pharmacist, and physician representatives facilitate periodic, announced, focus groups of frontline practitioners for off the record discussions to learn about perceived problems and risks with the medication use system. 36% 36% 29% 55 Questions? 56 19

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Improving Staff Education

More information

Objectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals

Objectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals ICAHN Aggregate Results ISMP Medication Safety Self Assessment for Hospitals Matthew Fricker, RPH, MS, FASHP Rebecca Lamis, PharmD, FISMP January 23, 2014 1 Objectives Report the demographic characteristics

More information

MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012

MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012 MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY April 2009 September 2012 Institute for Safe Medication Practices Canada Institut pour l utilisation sécuritaire des médicaments du

More information

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Susan M. Proulx, Pharm.D. President, Med-E.R.R.S. Subsidiary of ISMP (www.med-errs.com) Mission of ISMP Translate errors into education

More information

Reducing the risk of serious medication errors in community pharmacy practice

Reducing the risk of serious medication errors in community pharmacy practice Reducing the risk of serious medication errors in community pharmacy practice Eastern Medicaid Pharmacy Administrators Association (EMPAA) November 1, 2017 Newport, Rhode Island Michael R. Cohen, RPh,

More information

Report on the. Results of the Medication Safety Self- Assessment for Long Term Care. Ontario s Long-Term Care Homes

Report on the. Results of the Medication Safety Self- Assessment for Long Term Care. Ontario s Long-Term Care Homes Report on the Results of the Medication Safety Self- Assessment for Long Term Care by Ontario s Long-Term Care Homes Report Submitted to: Ministry of Health And Long-Term Care Prepared by: ISMP Canada

More information

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur

More information

APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS

APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS Use the following checklists in the appropriate areas of your office, facility or practice to assist in preventing medications errors:

More information

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY Continuous Quality Improvement IMPACT OF Steven R. Abel, PharmD, FASHP TECHNOLOGY ON Nital Patel, PharmD. MBA MEDICATION SAFETY Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate Ismaila D Badjie

More information

Introducing ISMP s New Targeted Best Practices for

Introducing ISMP s New Targeted Best Practices for Introducing ISMP s New Targeted Best Practices for 2018-2019 Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute for Safe Medication Practices (ISMP) Horsham, PA 1 Disclosure The

More information

Re-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA

Re-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA Re-Engineering Medication Processes to Capitalize on Technology Jane Englebright, PhD, RN Vice President, Quality HCA Who is HCA? % % % % U.K. % % % Switzerland % %% % % % % % %% % % % % % % % %% % % %

More information

Definitions: In this chapter, unless the context or subject matter otherwise requires:

Definitions: In this chapter, unless the context or subject matter otherwise requires: CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable

More information

Medication Safety Technology The Good, the Bad and the Unintended Consequences

Medication Safety Technology The Good, the Bad and the Unintended Consequences Medication Safety Technology The Good, the Bad and the Unintended Consequences Michelle Mandrack RN, MSN Director of Consulting Services Matthew Fricker, RPh, MS Program Director 1 Objectives Consider

More information

Culture of Safety: What s in Your Toolbox?

Culture of Safety: What s in Your Toolbox? Culture of Safety: What s in Your Toolbox? Kathy Ghomeshi, PharmD, BCPS Medication Safety Specialist Victoria Serrano Adams, PharmD, FASHP, FCSHP Director of Pharmaceutical Services UCSF Medical Center

More information

Practice Spotlight. Children's Hospital Central California Madera, California

Practice Spotlight. Children's Hospital Central California Madera, California Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW

More information

Safe Medication Practices

Safe Medication Practices Safe Medication Practices Patient Safety: Preventing Adverse Events OHA Conference Renaissance Toronto Hotel at SkyDome Toronto June 14, 2004 David U President & CEO, ISMP Canada Agenda ISMP Canada Patient

More information

(10+ years since IOM)

(10+ years since IOM) Medication Errors We're Looking Down the Tunnel and Seeing Light (10+ years since IOM) Michael R. Cohen, RPh, MS, ScD Institute for Safe Medication Practices mcohen@ismp.org 1 Disclosure Information Michael

More information

2017 Good Catch Program: Blueprint Companion Guide

2017 Good Catch Program: Blueprint Companion Guide 2017 Good Catch Program: Blueprint Companion Guide EXECUTIVE SUMMARY The following document provides guidance to accompany the recommended strategies listed within the Blueprint for Success, a comprehensive

More information

Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall. Total. Application Analysis 1.

Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall. Total. Application Analysis 1. Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall Application Analysis Total 1. CULTURE 2 12 4 18 A. Assessment of Patient Safety Culture 1. Identify work settings

More information

Medication Safety in LTC. Objectives. About ISMP Canada

Medication Safety in LTC. Objectives. About ISMP Canada Medication Safety in LTC Part II -Vulnerabilities in the Medication Use Process and Strategies to Enhance Medication Safety Lynn Riley, RN ISMP Canada Thursday, October 20, 2011 Objectives At the end of

More information

PHARMACY SERVICES/MEDICATION USE

PHARMACY SERVICES/MEDICATION USE 25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and

More information

Human Factors. Frank Federico, RPh. This presenter has nothing to disclose.

Human Factors. Frank Federico, RPh. This presenter has nothing to disclose. Human Factors Frank Federico, RPh This presenter has nothing to disclose. 25 February 2015 Culture Learning System Improvement and Measurement Transparency Continuous Learning Accountability Teamwork &

More information

Report from the Medication Safety Self Assessment (MSSA)

Report from the Medication Safety Self Assessment (MSSA) Report from the Medication Safety Self Assessment (MSSA) NSW PUBLIC HOSPITALS Feb 2007 - Nov 2007 2 Report from the Medication Safety Self Assessment (MSSA) NSW PUBLIC HOSPITALS 3 Clinical Excellence Commission

More information

Shifting from Blame-&-Shame to a Just-and-Safe Culture

Shifting from Blame-&-Shame to a Just-and-Safe Culture Shifting from Blame-&-Shame to a Just-and-Safe Culture Barb Sproll Medication Safety Pharmacist Winnipeg Regional Health Authority 29 May 2018 Conflict of Interest I have no conflicts to disclose. Objectives:

More information

End-to-end infusion safety. Safely manage infusions from order to administration

End-to-end infusion safety. Safely manage infusions from order to administration End-to-end infusion safety Safely manage infusions from order to administration New demands and concerns 56% 7% of medication errors are IV-related. 1 of high-risk IVs are compounded in error. 2 $3.5B

More information

PGY1 Medication Safety Core Rotation

PGY1 Medication Safety Core Rotation PGY1 Medication Safety Core Rotation Preceptor: Mike Wyant, RPh Hours: 0800 to 1730 M-F Contact: (541)789-4657, michael.wyant@asante.org General Description This rotation is a four week rotation in duration.

More information

To establish a consistent process for the activity of an independent double-check prior to medication administration, where appropriate.

To establish a consistent process for the activity of an independent double-check prior to medication administration, where appropriate. TITLE INDEPENDENT DOUBLE-CHECK SCOPE Provincial, Clinical DOCUMENT # PS-60-01 APPROVAL LEVEL Senior Operating Officer, Pharmacy Services SPONSOR Provincial Medication Management Committee CATEGORY Patient

More information

Improving Safety Practices Anticoagulation Therapy

Improving Safety Practices Anticoagulation Therapy Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable

More information

Preventing Medical Errors

Preventing Medical Errors Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.

More information

How Pharmacy Informatics and Technology are Evolving to Improve Patient Care

How Pharmacy Informatics and Technology are Evolving to Improve Patient Care How Pharmacy Informatics and Technology are Evolving to Improve Patient Care HealthcareIS.com 2 Table of Contents 3 Impact of Emerging Technologies 3 CPOE 5 Automated Dispensing Machines 6 Barcode Medication

More information

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM BOARD OF PHARMACY SPECIALTIES CRITICAL CARE PHARMACY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2017/FOR USE ON FALL 2018 EXAMINATION AND FORWARD UNDERSTANDING THE

More information

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance Pharmacist Role in Medication Safety and Regulatory Compliance Janet Greiwe Vice President, Systems Management Cleveland County Health System Objectives By the end of this presentation, you should be able

More information

One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration

One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital Northwestern Memorial Hospital Chicago, Illinois

More information

Neonatal Intensive Care Unit EUHM

Neonatal Intensive Care Unit EUHM Neonatal Intensive Care Unit Rotation @ EUHM Preceptor: Office: Tabitha Carney, PharmD, MBA, MSHA EUHM MOT 3 rd Floor in Special Care Nurseries Hours: 0800-1630 Desk: 404-686-8902 Pager: 12621 EUHM Cell

More information

To understand the formulary process from the hospital perspective

To understand the formulary process from the hospital perspective Formulary Process Christine L. Ahrens, Pharm.D. Cleveland Clinic Cleveland Clinic 2011 Goal and Objectives To understand the formulary process from the hospital perspective p To list the various panels

More information

Department of Pharmacy Services PGY1 Residency Program. Residency Manual

Department of Pharmacy Services PGY1 Residency Program. Residency Manual Department of Pharmacy Services PGY1 Residency Program Residency Manual 1 TABLE OF CONTENTS I. Introduction II. General Program Goals III. Residency Program Purpose Statement IV. Program s Goals V. Residency

More information

Medication Management Checklist for Supportive Living Early Adopter Initiative. Final Report. June 2013

Medication Management Checklist for Supportive Living Early Adopter Initiative. Final Report. June 2013 Medication Management Checklist for Supportive Living Early Adopter Initiative Final Report June 2013 Table of Content Executive Summary... 1 Background... 3 Method... 3 Results... 3 1. Participating

More information

The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009

The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009 The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009 About me I am someone s mother, wife, daughter, granddaughter, sister, aunt, cousin and niece. I

More information

student interests. The 1. Develop of error schema. develop

student interests. The 1. Develop of error schema. develop Sample Medication Safety APPE Student Rotation Rotation Description The medication safety rotation willl help students become familiar with the key principles utilized in hospitals and health systems to

More information

Introduction to Pharmacy Practice

Introduction to Pharmacy Practice Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians

More information

Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration

Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications

More information

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 TITLE / DESCRIPTION: SAFETY PROCEDURES FOR MEDICATION USE DEPARTMENT: Pharmacy PERSONNEL: All Pharmacy Personnel EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 Leadership and Culture A culture

More information

Keenan Pharmacy Care Management (KPCM)

Keenan Pharmacy Care Management (KPCM) Keenan Pharmacy Care Management (KPCM) This program is an exclusive to KPS clients as an additional layer of pharmacy benefit management by engaging physicians and members directly to ensure that the best

More information

17/06/2014. Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption. Objectives. Cancer Care Ontario

17/06/2014. Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption. Objectives. Cancer Care Ontario Objectives Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption Dr. Vishal Kukreti, MD, FRCPC, MSc Clinical Lead, etools and Technology Cancer Care Ontario

More information

Encouraging pharmacy involvement in pharmacovigilance; an international perspective.

Encouraging pharmacy involvement in pharmacovigilance; an international perspective. Encouraging pharmacy involvement in pharmacovigilance; an international perspective. Michael R. Cohen, RPh, MS, ScD (hon) DPS (hon) Chairperson, International Medication Safety Network and President, Institute

More information

A Discussion of Medication Error Reduction Strategies

A Discussion of Medication Error Reduction Strategies A Discussion of Medication Error Reduction Strategies By: Donald L. Sullivan, R.Ph., Ph.D. Program Number: 071067-011-01-H05 C.E.U.s: 0.1 Contact Hours: 1 hour Release Date: 4/1/11 Expiration Date: 4/1/14

More information

DISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs)

DISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs) 2017 DISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs) This Interpretive Document was approved by ARNNL Council in 2017 and replaces Dispensing by Registered Nurses

More information

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS MEDICATION ERRORS Patients depend on health systems and health professionals to help them stay healthy. As a result, frequently patients receive drug therapy with the belief that these medications will

More information

The Colorado ALTO Project

The Colorado ALTO Project Using Alternatives to Opioids (ALTOs) in Hospital Emergency Departments PRE-LAUNCH CHECKLIST Based on the 2017 Opioid Prescribing & Treatment Guidelines Colorado ALTO Project Champion Sets the direction

More information

Legislating Patient Safety: The California Experience. October 2003

Legislating Patient Safety: The California Experience. October 2003 Legislating Patient Safety: The California Experience October 2003 The Problem: Preventable medical errors are a huge and largely invisible cause of death in California and nationwide. In CA, an estimated

More information

Overview of the Leapfrog CPOE Evaluation Tool. An educational update to the HIMSS EIS Steering Committee August 13, 2009

Overview of the Leapfrog CPOE Evaluation Tool. An educational update to the HIMSS EIS Steering Committee August 13, 2009 Overview of the Leapfrog CPOE Evaluation Tool An educational update to the HIMSS EIS Steering Committee August 13, 2009 1 Overview What is the CPOE Evaluation Tool? Development of the Tool Why is Tool

More information

To describe the process for the management of an infusion pump involved in an adverse event or close call.

To describe the process for the management of an infusion pump involved in an adverse event or close call. TITLE INFUSION PUMPS FOR MEDICATION & PARENTERAL FLUID ADMINISTRATION SCOPE Provincial, Clinical DOCUMENT # PS-70-01 APPROVAL LEVEL Executive Leadership Team SPONSOR Provincial Medication Management Committee

More information

BETA HEALTHCARE GROUP

BETA HEALTHCARE GROUP BETA Healthcare Group is focused on improving reliability and reducing risk exposure in emergency departments. BETA provides our member hospitals and medical groups the opportunity for significant reduction

More information

Example of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)

Example of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen) Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia

More information

Compounded Sterile Preparations Pharmacy Content Outline May 2018

Compounded Sterile Preparations Pharmacy Content Outline May 2018 Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of

More information

Achieving safety in medication management through barcoding technology

Achieving safety in medication management through barcoding technology Achieving safety in medication management through barcoding technology Kara Marx, RN, FACHE, FHIMSS Vice President of Information Services Sharp Healthcare. SESSION OBJECTIVES Describe the primary activities

More information

2018 LEAPFROG HOSPITAL SURVEY ORGANIZATIONAL BINDER

2018 LEAPFROG HOSPITAL SURVEY ORGANIZATIONAL BINDER 2018 LEAPFROG HOSPITAL SURVEY ORGANIZATIONAL BINDER TABLE OF CONTENTS Section # Tab # Overview 1 Section 1: Basic Hospital Information 2 Section 2: Medication Safety CPOE 3 Section 3: Inpatient Surgery

More information

To prevent harm to patients from adverse medication events involving high-alert medications.

To prevent harm to patients from adverse medication events involving high-alert medications. TITLE MANAGEMENT OF HIGH-ALERT MEDICATIONS DOCUMENT # PS-46-01 PARENT DOCUMENT LEVEL LEVEL 1 PARENT DOCUMENT TITLE Management of High-alert Medications Policy APPROVAL LEVEL Alberta Health Services Executive

More information

Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery

Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery Dr. Vishal Kukreti, MD, FRCPC, MSc Clinical Lead, Systemic

More information

Introduction. Medication Errors. Objectives. Objectives. January What is a Medication Error? Define medication errors/variances

Introduction. Medication Errors. Objectives. Objectives. January What is a Medication Error? Define medication errors/variances Medication Errors Earlene Spence, Pharm.D., Miami VA Healthcare System Neena John, Pharm.D., Miami VA Healthcare System Eva Moreira, Pharm.D., Miami VA Healthcare System Chantal Chan, Pharm.D., Miami VA

More information

Required Organizational Practices Resources for 2016

Required Organizational Practices Resources for 2016 Required Organizational Practices Resources for 2016 ROPs Tests for Compliance Things to Consider Available Resources CLIENT IDENTIFICATION Working in partnership with clients and families, at least two

More information

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,

More information

From Big Data to Big Knowledge Optimizing Medication Management

From Big Data to Big Knowledge Optimizing Medication Management From Big Data to Big Knowledge Optimizing Medication Management Session 157, March 7, 2018 Dave Webster, RPh MSBA, Associate Director of Pharmacy Operations, URMC Strong Maria Schutt, EdD, Director Education

More information

Improving the Patient Experience Through Pharmacy

Improving the Patient Experience Through Pharmacy Rick Burnett Chief Operating Officer Kenneth Maxik Director, Patient Safety & Pharmacy Compliance Improving the Patient Experience Through Pharmacy August 19, 2015 Speakers Rick Burnett, PharmD, FACHE

More information

NEW JERSEY. Downloaded January 2011

NEW JERSEY. Downloaded January 2011 NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if

More information

Critical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

Critical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital Critical Access Hospitals Site Visit Summary 2014 2015 Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital 2014 2015 13 Critical Access Hospitals (CAH) Site Visits Compounded

More information

Communication and Teamwork for Patient Safety 1.0 Contact Hour Presented by: CEU Professor

Communication and Teamwork for Patient Safety 1.0 Contact Hour Presented by: CEU Professor Communication and Teamwork for Patient Safety 1.0 Contact Hour Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2008 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution

More information

CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL

CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL PERFORMANCE IMPROVEMENT Introduction to terminology and requirements Performance Improvement Required (Board of Pharmacy CQI program, The Joint Commission, CMS

More information

Running head: MEDICATION ERRORS 1. Medications Errors and Their Impact on Nurses. Kristi R. Rittenhouse. Kent State University College of Nursing

Running head: MEDICATION ERRORS 1. Medications Errors and Their Impact on Nurses. Kristi R. Rittenhouse. Kent State University College of Nursing Running head: MEDICATION ERRORS 1 Medications Errors and Their Impact on Nurses Kristi R. Rittenhouse Kent State University College of Nursing MEDICATION ERRORS 2 Abstract One in five medication dosages

More information

Profiles in CSP Insourcing: Tufts Medical Center

Profiles in CSP Insourcing: Tufts Medical Center Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)

More information

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers Managing Treatment With Oral Oncology Medications An Educational Toolkit for Health Care Providers Acknowledgment Novartis Pharmaceuticals Corporation would like to thank Jody Pelusi, PhD, FNP, AOCNP,

More information

Objective Competency Competency Measure To Do List

Objective Competency Competency Measure To Do List 2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:

More information

Medication Errors An Opportunity to Improve

Medication Errors An Opportunity to Improve FSHP Medication Errors An Opportunity to Improve Laura Monroe-Duprey, BS Pharm, PharmD Joanie Spiro Stevens, PharmD, BCPS Disclosure Laura Monroe-Duprey - I do not have (nor does any immediate family member

More information

The Joint Commission Medication Management Update for 2010

The Joint Commission Medication Management Update for 2010 Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program

More information

Identifying Errors: A Case for Medication Reconciliation Technicians

Identifying Errors: A Case for Medication Reconciliation Technicians Organization: Solution Title: Calvert Memorial Hospital Identifying Errors: A Case for Medication Reconciliation Technicians Program/Project Description and Goals: What was the problem to be solved? To

More information

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations PAGE: 1 of 6 SCOPE: Centene Corporate Pharmacy Department, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, and

More information

Session 2 Improving Narcotics and Opiate Management

Session 2 Improving Narcotics and Opiate Management Session 2 Improving Narcotics and Opiate Management Frank Federico, RPh, IHI Executive Director Steve Meisel, Pharm.D., IHI Faculty January 31,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH,

More information

Case Study from Parallon

Case Study from Parallon Case Study from Parallon Improving Compliance with the Smart Pump drug library across a large hospital system Part 2 Monday, July 10, 2017 AAMI Foundation Vision: To drive the safe adoption and safe use

More information

PGY-1 Pharmacy Practice

PGY-1 Pharmacy Practice Lutheran Health Network PGY-1 Pharmacy Practice Residency Program LHN Pharmacy Residency Program Mission Statement The mission of the LHN Pharmacy Residency Program is to empower pharmacy residents to

More information

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System Scott R. Smith, MSPH, PhD Center for Outcomes & Evidence Agency for Healthcare Research & Quality July 20,

More information

Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist

Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist CPSI Safe Surgery Saves Lives Workshop Montréal, QC 29Mar2011 Julie Greenall, RPh, BScPhm, MHSc, FISMPC Institute

More information

Licensed Pharmacy Technicians Scope of Practice

Licensed Pharmacy Technicians Scope of Practice Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated

More information

CPhT Program Recognition Attestation Form

CPhT Program Recognition Attestation Form About this Form Beginning in 2020, CPhT applicants must have completed a PTCB-recognized education/training program or have equivalent work experience in order to be eligible for certification. The purpose

More information

PHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s)

PHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s) PRECEPTOR CHECKLIST /SIGN-OFF PHCY 471 Community IPPE Student Name Supervising Name(s) INSTRUCTIONS The following table outlines the primary learning goals and activities for the Community IPPE. Each student

More information

MEDMARX ADVERSE DRUG EVENT REPORTING

MEDMARX ADVERSE DRUG EVENT REPORTING MEDMARX ADVERSE DRUG EVENT REPORTING Comparative Performance Reporting Helps to Reduce Adverse Drug Events Are you getting the most out of your adverse drug event (ADE) data? ADE reporting initiatives

More information

Hallmarks of Patient Safety and Quality Improvement Programs in Pharmacy Practice

Hallmarks of Patient Safety and Quality Improvement Programs in Pharmacy Practice Hallmarks of Patient Safety and Quality Improvement Programs in Pharmacy Practice Jordan T. Daniel, PharmD Wednesday, May 10, 2017 Kimberly McDonough Spring Seminar Rhode Island Pharmacy Foundation Disclosure

More information

Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.

Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq. Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations

More information

Policies Approved by the 2017 ASHP House of Delegates

Policies Approved by the 2017 ASHP House of Delegates House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare

More information

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations

POLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations PAGE: 1 of 5 SCOPE: Centene Corporate Pharmacy Solutions, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, Pharmacy

More information

ALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA

ALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA ALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA QUALITY IMPROVEMENT PROGRAM 2010 Overview The Quality

More information

ADMINISTRATIVE POLICY & PROCEDURE PATIENT SAFETY PLAN

ADMINISTRATIVE POLICY & PROCEDURE PATIENT SAFETY PLAN PAGE #: 1 of 6 CROSS REFERENCES: Administrative Policy PI-01: Administrative Policy PI-03: Administrative Policy RI-20: Administrative Policy EC-25: Sentinel Event Risk Management Plan Guidelines for Disclosure

More information

E.H.R. s and Improving Patient Safety - What Has Been the Real Impact?

E.H.R. s and Improving Patient Safety - What Has Been the Real Impact? E.H.R. s and Improving Patient Safety - What Has Been the Real Impact? Presented by: Mary Erickson, RN, HTS Accounting Manager HTS, a division of Mountain Pacific Quality Health Foundation 1 Understand

More information

PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS

PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS PURPOSE The pre-survey questionnaire serves to maximize the

More information

APEx Program Standards

APEx Program Standards APEx Program Standards The following standards are the basis of the APEx program. Level 1 standards are indicated in bold. Standard 1: Patient Evaluation, Care Coordination and Follow-up The radiation

More information

Policy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.

Policy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription. POLICY POLICY PURPOSE: The purpose of this policy is to provide a foundation for safe communication of medication and nutritional orders in-scope, thereby reducing the potential for preventable medication

More information

Medication Safety Issues and Recommended Strategies Related to Sterile Compounding PharMEDium Lunch and Learn Series LUNCH AND LEARN

Medication Safety Issues and Recommended Strategies Related to Sterile Compounding PharMEDium Lunch and Learn Series LUNCH AND LEARN LUNCH AND LEARN Medication Safety Issues and Recommended Strategies Related to Sterile Compounding January 12, 2018 Featured Speaker: Christina Michalek, BS, RPh, FASHP Medication Safety Specialist Institute

More information

October 11 13, 2018 Dallas, TX Poster Submission Rules & Format t Guidelines

October 11 13, 2018 Dallas, TX Poster Submission Rules & Format t Guidelines October 11 13, 2018 Dallas, TX Poster Subm mission Rule es & Format Guid delines 2018 American Society of Health System Pharmacists, Inc. ASHP is a service mark of the American Society of Health System

More information

N ATIONAL Q UALITY F ORUM. Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT

N ATIONAL Q UALITY F ORUM. Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT N ATIONAL Q UALITY F ORUM Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT NATIONAL QUALITY FORUM Foreword Every person who seeks care in a healthcare facility should expect to receive

More information

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that hospital. 1 2 3 Note that an actual variance occurs when

More information